chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Painful joints all over my body, especially hands, shoulders, upper back, ankles, knees; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the left arm on 26Mar2021 at 09:00 (at the age of 66-years-old) as single dose for COVID-19 immunisation. Medical history included hypertension, thyroid disorder, GERD and cholesterol. The patient was allergic to penicillin, sulfa drugs and codeine (MANUFACTURER UNKNOWN). Concomitant medications included diltiazem (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN); all from an unknown date and for unknown indications. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021, the patient experienced painful joints all over her body, especially hands, shoulders, upper back, ankles and knees. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event painful joints all over my body, especially hands, shoulders, upper back, ankles and knees were unknown at the time of this report.    No follow-up attempts are needed. No further information is expected.
Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported).    No concomitant product reported by reporter.  It was reported that 100 patients were administered an invalid dose of Moderna COVID-19 bivalent booster. The nurse had no standing order other than what they had for second booster, when administering bivalent boosters, so they assumed same dose as second booster and administered 0.25mL to uncompromised adults. This case was for one of the patient among the 100 patients who were administered an invalid dose of Moderna COVID-19 bivalent booster.   It was reported that CDC had recommended to revaccinate the patients with full dose of 0.5mL.  No treatment medication reported by reporter.
I got my first Moderna vaccine on 9/22 /21 . After receiving the shot I became extremely flushed and had to lie down . An hour later my blood pressure was 87/52. I drank fluids to raise my blood pressure. A week later I began to experience heart palpitations. I considered it was possibly dehydration so I continued to drink fluids . The palpitations continued . I decided to go to the urgent care . They did an EKG that showed sinus  Rhythm with possible ischemia. I went to the ER for a repeat EKG and blood work ..My bloodwork was normal . The palpitations have continued with a run of SVT at 148 beats .
Hives showed up all over body starting from forearm of arm where Moderna was injected. Over two hours, hives showed up  on scalp, neck, thighs, breasts. After Benadryl and Claritin,  new hives finally stopped appearing.
is very painful; The numbness started on the right arm where I received the shot; The numbness started on the right arm where I received the shot , it started travelling to other parts of my body; I started having symptoms of rash; itchy skin and eyes; itchy skin and eyes; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 02Aug2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Aug2021, the patient experienced i started having symptoms of rash, itchy skin and eyes. On an 07Aug2021, the patient experienced is very painful, the numbness started on the right arm where i received the shot, it started travelling to other parts of my body. Reportedly, the patient received the first Pfizer Coved 19 shot 02Aug2021, less than a week later the patient started having symptoms of rash, itchy skin and eyes and then on the 5th day numbness, the numbness started on the right arm where the patient received the shot, it started traveling to other parts of the patient body and as of 5 weeks later, all numbness had not gone away and was located at 7 seven locations of the patient body and was very painful. The patient(s) General PC asked the patient to see the Neurologist. The patient needed help a little sooner than 27Sep. The outcome of the events I started having symptoms of rash, itchy skin and eyes was unknown. The outcome of the events is very painful, the numbness started on the right arm where i received the shot and it started travelling to other parts of my body and was not recovered.  No follow-up attempts are possible. No further information is expected.
INCOMPLETE DOSE(PERSON WHO GAVE VACCINE TO PATIENT MUST NOT HAVE STUCK THE NEEDLE IN FAR ENOUGH BECAUSE WHEN HE PULLED IT OUT ALL THE MEDICINE POURED OUT  OF ARM DOWN OFF ELBOW); POSSIBLE INCORRECT ADMINISTRATION(PERSON WHO GAVE VACCINE TO PATIENT MUST NOT HAVE STUCK THE NEEDLE IN FAR ENOUGH BECAUSE WHEN HE PULLED IT OUT ALL THE MEDICINE POURED OUT  OF ARM DOWN OFF ELBOW); This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced incomplete dose (person who gave vaccine to subject must not have stuck the needle in far enough because when he pulled it out all the medicine poured out of arm down off elbow), and possible incorrect administration (person who gave vaccine to subject must not have stuck the needle in far enough because when he pulled it out all the medicine poured out of arm down off elbow). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. The outcome of the incomplete dose(person who gave vaccine to patient must not have stuck the needle in far enough because when he pulled it out all the medicine poured out of arm down off elbow) and possible incorrect administration(person who gave vaccine to patient must not have stuck the needle in far enough because when he pulled it out all the medicine poured out of arm down off elbow) was not reported. This report was non-serious.
First injection of SHINGRIX was given on May 3, 2018. I did not experience any side effects except mild soreness at the injection site. On July 19, 2018, Pharmacist administered the second dosage of SHINGRIX. That evening, I had a mild upset stomach which was relieved by my taking TUMS. During the night of July 19, 2018, I experienced significant shivering and muscle pain, starting at 12:30AM, I was shaking uncontrollable. The shivering lasted approximately 6 hours. The muscles of both feet and legs spasmed for a couple of hours despite my getting out of bed, stretching the muscles, and massaging my feet and legs. This morning by 7AM, the symptoms subsided.
Left leg swollen and hot to touch for 2 days. Benadryl given by parent.
head aches, chest pain, left back pain and feeling shaky, felt like my lips was swollen, nausea and metallic taste in my mouth. chills, stomach pain, leg pain, feeling fatigued
flu; Initial information received on 27-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional.  This case involve a patient (unknown age) who experienced flu (influenza) , when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) unknown latency following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for influenza.  There will be no information available on the batch number for this case.
pt s/p vax 19NOV97;pt woke up this AM 21NOV97 w/redness, warmth/swelling surrounding vax area;
Localized reddened area left anterior thigh, afebrile, Orapred 3tsp. in officethen 11/2tsp. daily for 4 days.  Recommend cool compresses and Motrin for pain and inflammation.  Advised if pain worsens, develops a high temp or area of erythema enlarges return to office.
Information has been received from a healthcare worker concerning a female who was vaccinated with a first dose of GARDASIL. Subsequently the patient developed severe headaches. At the time of this report, the outcome was unknown. Additional information has been requested.
Arm pain in area where shot was placed. Swelling and redness of the area. Hot and painful to the touch. I have been instructed to take BENADRYL and ibuprofen for the symptoms.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history or concurrent condition was not provided. On 09-JUL-2015, the patient received a dose of improperly stored MMR II 0.5 ml (lot # J014876, expiration date 21-NOV-2015, therapy type rHA (recombinant human albumin)) subcutaneously. Concomitant drug was not reported. No adverse effects were reported. It was unknown whether the patients sought medical attention. This is one of several reports received from the same reporter. Additional information has been requested.
I accidently used a syringe that I thought was loaded with vaccine(we preload them) and injected it into the patient's arm. It turned out that the plunger had been pulled back but no vaccine was in it. I apologized and did administer a section shot with the vaccine so the patient was injected with a needle twice. I called the patient's home this morning and her arms is a little sore as expected but no other symptoms were present.
This spontaneous report as received from a healthcare worker, refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 31-MAR-2016, the patient was vaccinated with a 0.5 ml dose of improperly stored VARIVAX (Merck) (which had a lot # of L040419 and an expiration date of 14-OCT-2014; however, dosage number and route of administration were not reported). Nonetheless, no adverse effects were reported. Another batch of VARIVAX (Merck) (which had a lot # of L043624 and an expiration date of 03-NOV-2017) had been improperly stored but it was not reported whether it had been administered. The vaccines experienced the following temperature excursions on the following dates: 10 F for 2 hours and 15 minutes on 24-MAR-2016; 12.4 for 2 hours and 15 minutes on 26-MAR-2016; and 10.4 F for 2 hours and 15 minutes on 30-MAR-2016. Reportedly, there had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter.
ACUTE PULMONARY EMBOLISM 12/8/2021 BENIGN ESSENTIAL TREMOR  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/8/2021 BENIGN ESSENTIAL TREMOR
Pt vaccinated 1-24 with ZOSTAVAX. On 1-27 Pt walked into clinic stating she had reaction. Pt temp 101, arm warm, spreading redness, slight itching.
Patient is a 4 year old male due for routine vaccinations. Patient received Tdap instead of DTap vaccine. It was realized when the patient returned for his PPD reading. Physician informed and indicated that it was not an ideal vaccine but will provide sufficient immunization.
redness, swelling, pain, from shoulder to elbow.  began the evening of injection and worsened over next 2 days.  treated with levaquin for cellulitis.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: patient had a seizure that lasted a few seconds-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Seizure-Mild
Pt experienced the following symptoms: light headedness, headache, severe edema on entire upper left arm, swelling of an area of 6" X 10" centering at the Sub Q injection site of Yellow Fever, and very hot skin.
Since I have received my booster shot on Sunday January 10,2022, I would like you to know that Monday January 11th I came home from work I have slept until Wednesday morning. when the 12 2022. I have called my doctor I went in to see him this Morning at 8 am January 13,2022. Symptoms are lower back pain, dizziness, head pain neck pain and also nausea. He game Ondansetron HCL. Also, Ibuprofen 800 mg tab for pain I am out of my 2 jobs work until Monday January 17th I can go back. I am having a real bad time with this shot I have received the  Moderna.
Myocarditis was the main concerning symptom experienced the day after vaccination. The symptom started around 14 hours after the vaccination. Advil was taken for general pain relief. Within 24 hours, the Myocarditis was gone.
Patient requested that we report the following adverse events: Large swollen knot (large ball) at injection site, wide spread rash on both arms, both legs and stomach.
Rash on forehead/neck that is itching/burning. Patient treated with Acyclovir 800mg, 1 tab 5 times daily for 7 days
received dose from vial refrigerated more than 30 days; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received dose from vial refrigerated more than 30 days) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received dose from vial refrigerated more than 30 days). On 15-Sep-2021, EXPIRED PRODUCT ADMINISTERED (received dose from vial refrigerated more than 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.
PATIENT COMPLAINING OF TIGHTNESS IN CHEST, NUMBESS ON LEFT ARM AND FACE. PATIENT SEEMED TALKATIVE AND ALERT. EMS AT CLINIC REQUESTED. HE WAS EVALUATED BY EMS  AND TRANSPORTED TO A AREA HOSPITAL
Right upper lobe of lung collapsed.  12/7/07 Reviewed hospital medical records which reveal patient experienced 2 week of perisstent nonproductive cough w/intermittent SOB, wheezing & sharp stabbing right neck pain beginning 1 week s/p vax.  Persistent RUL collapse & possible foreign body aspiration which was ruled out.  Admitted 11/14-11/18/2007.  Tx w/antibiotics, PPD & aggressive pulmonary toilet.  Pulmonary consult done.   FINAL DX: no d/c summary available, admit & d/c dates obtained from ROI.  Bronchoscopy revealed asthma w/RUL collapse.
Information has been received from a physician concerning an adolescent female patient who on an unspecified date, was vaccinated with GARDASIL vaccine. The physician reported that the patient experienced injection site pain. The outcome is unknown. This is one of several cases from the same source. Additional information has been requested.
Patient is a 92 y.o. female with a history of permanent afib, HFpEF, Hypothyroidism who presented to hospital 9/11/2023 with weakness, fever and malaise. Covid-19 positive, troponin 48, ntpro 2821. Hospitalization complicated by Afib with RVR. CTPA on admission with bilateral pleural effusions, treated with IV diuresis.   1. Acute hypoxemic respiratory failure: required 2L NC on admit. Multifactorial due to cardiogenic pulmonary edema and covid-19. Weaned to RA at discharge. 2. COVID-19 infection: symptom onset 9/9/23. Positive on admit. Steroids, remdesivir in house, no indication for continuation at discharge. 3. Permanent Atrial fibrillation with RVR: per history, afib on admit. Continued home coumadin. Dilt drip transitioned to PO then d/ced with bradycardia. Titrated home BB, f/u with PCP. 4. Acute decompensated heart failure with preserved EF: known history. EF 55-60% 2019. Ntpro 2821 with pleural effusion as above. IV lasix for diuresis, PO transition 9/16/23. F/u with PCP for lab monitoring, further titration 5. Mitral valve regurgitation: per history, s/p bioprosthetic valve replacement. 6. Tricuspid regurgitation: per history.  7. Right ICA stenosis: noted on cta head on admit with 87% stenosis on right ICA. Continued coumadin. 8. Incidental findings: simple cyst in left kidney and stable low density lesions in liver that are stable on CT. 9. Code status: DNRCC, confirmed with daughter, HCPOA on admit.
I woke up at 1:30 am with a sore arm and went into the bathroom to get some motrin for the soreness.  I started to feel dizzy and a bit nauseous...suddenly I woke up on the floor.  I had passed out while standing at the counter.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 29-APR-2016 the patient was vaccinated with an improperly stored (30.8 Fahrenheit for 9 hours and 67 Fahrenheit for 9 hours) dose of GARDASIL 9 (lot # L018351, expiration date 11-AUG-2017, dose and route unknown). No adverse effect was reported. Additional information has been requested.
1st Pfizer dose April 1, 2021 2nd Pfizer dose April 29, 2021 Pfizer booster Aug 19, 2021  Admitted 01/06/22 with hypoxic respiratory failure 2/2 covid19 pna.
Headache, Fever, Chills, Nausea, Light Sensitivity, Cognitive Disfunction, Weight Loss, Muscle Ache, Limb Weakness.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 13-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Sep2022 as dose 4 (booster), single (Lot number: GJ5342) at the age of 13 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 23Jun2021 as dose 1, single (Lot number: EW0191), on 14Jul2021 as dose 2, single (Lot number: EW0198) and on 20Jan2022 as dose 3 (booster), single (Lot number: FK9729) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: Covid positive at home test after previous negative test; Positive, notes: Covid positive at home test after previous negative test. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Developed itchy rash on arms on torso 3 days after Td. Took Benadryl. Resolved 4 days later.
Numbness and tingling in my face, it's around my chin; Numbness and tingling in my face, it's around my chin /I felt kind of weird but I definitely felt tingling; I felt kind of weird but I definitely felt tingling; This is a spontaneous report received from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9264), on 03Feb2021 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient asking if she should get her second dose of Pfizer's COVID vaccine the day of the present report, 24Feb2021, if she experienced numbness and tingling in her face after the first dose on 03Feb2021. Patient asked if getting only the 1st shot protected her in any way. Patient also stated that she was supposed to get her second shot the day of the present report (24Feb2021) and when she had her first shot, she should had contacted when she had it but she didn't and at the time of this report she was like worried, but she had a lot of numbness and tingling in her face, it was around her chin and they did not know, her daughter was looking up and she said she did not think she should get the second shot which she mean she felt fine otherwise, she felt kind of weird but she definitely felt tingling she was almost going to get back in (clarification unknown) but she decided to go home but it was like 15 minutes after. In response to further probing, patient stated that she did not know if she should get the second shot that was why she was asking, should she get the second dose. The events were reported as non-serious. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium, Systemic: Hypertension-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Medium